INTRODUCTION
Cardiac complications are important causes of morbidity and mortality in vascular surgery, and the reported rate of cardiac morbidity is often greater than 5% [1] . For these reasons, preoperative cardiac risk evaluation is an important part of vascular surgery. The American College of Cardiology (ACC) and the American Heart Association (AHA) introduced guidelines to detect and manage perioperative cardiac risk and to prevent cardiac complications after vascular surgery [2] . For preoperative noninvasive stress testing (NIST), the guidelines recommended that patients with active cardiac conditions (Table 1) should be evaluated and treated (class I). Patients who do not have Decompensated HF (NYHA functional class IV; worsening or new-onset HF) Significant arrhythmias High-grade atrioventricular block Mobitz II atrioventricular block Third-degree atrioventricular heart block symptomatic ventricular arrhythmias supra ventricular arrhythmias (including atrial fibrillation) with uncontrolled ventricular rate (HR greater than 100 beats per minute at rest) symptomatic bradycardia Newly recognized ventricular tachycardia Severe valvular disease Severe aortic stenosis (mean pressure gradient greater than 40 mmHg, aortic valve area less than 1.0 cm 2 , or symptomatic)
Symptomatic mitral stenosis (progressive dyspnea on exertion, exertional presyncope, or HF)
CCS, Canadian Cardiovascular Society; MI, myocardial infarction; HF, heart failure; NYHA, New York Heart Association; HR, heart rate.
a)
According to Campeau [4] .
May include "stable" angina in patients who are unusually sedentary.
c)
The American College of Cardiology National Database Library defines recent MI as more than 7 days but less than or equal to 1 month (within 30 days). The Lee's index uses six criteria: high-risk surgery, ischemic heart disease, congestive heart failure, cerebrovascular disease, insulin-dependent diabetes mellitus, and renal failure [3] .
active cardiac conditions are stratified into 3 groups by the Lee's revised cardiac risk index (Table 2) [3] . NIST may be considered for patients with high (class IIa) or intermediate (class IIb) risk, if it will change management.
However, in practice, NIST is sometimes performed without considering patient conditions. This study was aimed to identify the risk factors of postoperative major adverse cardiac event (MACE) when NIST is not performed before revascularization in chronic atherosclerotic lower extremity ischemia (CALEI). 
METHODS

Patients
Preoperative cardiac evaluation
First, careful history taking was done to identify prior angina pectoris or myocardiac infarction, heart failure, arrhythmia and valvular heart disease. Physical examination, routine blood test, electrocardiography (ECG), chest X-ray and echocardiography were performed routinely.
However, NIST (e.g., exercise ECG, adenosine MIBI scan and so on) or coronary angiography was not part of the routine examination. The only indication of NIST or coronary angiography was active cardiac conditions. thesurgery.or.kr Values are presented as mean (range) or number (%). Values are presented as mean (range) or number (%). 
RESULTS
A total of 459 patients underwent elective lower ex- Values are presented as number (%). MACE, major adverse cardiac event.
According to the Lee's revised cardiac risk index. (Table 5) . However, no independent risk factors of postoperative MACE were determined by the binary logistic regression model (Table 6 ).
Subgroup analysis was done excluding the endovascular treatment group that had no MACE (Tables 7, 8 ). The second multicenter Dutch Echoardiographic Cardiac Risk Evaluation study assessed the value of NIST in intermediate risk patients [9] . All patients received betablockers to achieve a resting heart rate of 60 to 65 beats/ min. There was no difference between the no NIST group and NIST group in cardiac death or MI at 30-days after surgery (1.8% vs. 2.3%, P = 0.62). In 2004, the Coronary Artery
Revascularization Prophylaxis trial was published [10] .
The study randomly assigned 510 patients scheduled for vascular surgery into the following two groups: coronary artery revascularization before surgery versus no revascularization before surgery. The rate of postoperative MI, defined by the elevated troponin level, was not different (12% vs. 14%, P = 0.37). Regarding the long-term outcome, mortality rate was not different at 2.7 years after randomization, (22% vs. 23%, P = 0.92).
In Besides the small number of high risk patients, our study has several limitations. The most important one is the retrospective design of the study. Also, we did not include a treatment group who underwent NIST. Therefore, it is impossible to compare no NIST group and the NIST group. However, we think that this study has significance as a large observational study of patients with CALEI in Korea.
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